LC-MS/MS method for simultaneous quantification of the first-line anti-tuberculosis drugs and six primary metabolites in patient plasma: Implications for therapeutic drug monitoring

Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes

Jotam G. Pasipanodya, Helen McIlleron, A. Burger et al. · The Journal of Infectious Diseases · 2013 · 447 citations · Full text

Determinants of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol Pharmacokinetics in a Cohort of Tuberculosis Patients

Helen McIlleron, Peter Wash, André Burger et al. · Antimicrobial Agents and Chemotherapy · 2006 · 243 citations · Full text

Pharmacotherapy, Antimicrobial Chemotherapy, Drug Resistance +16

Guidelines for treatment of drug-susceptible tuberculosis and patient care-2017 update

Jingtao Gao, Xiaochun Wang, Liang Fu et al. · Chinese Journal of Asthma · 2018 · 238 citations

Drug-susceptible Tuberculosis, Pulmonary Tuberculosis, Tuberculosis Prevention +6

Therapeutic Drug Monitoring for Slow Response to Tuberculosis Treatment in a State Control Program, Virginia, USA

Scott K. Heysell, Jane L. Moore, Suzanne Keller et al. · Emerging infectious diseases · 2010 · 154 citations · Full text

Tuberculosis Treatment, Tuberculosis Prevention, Pharmacotherapy +16

Simple and accurate quantitative analysis of 20 anti-tuberculosis drugs in human plasma using liquid chromatography–electrospray ionization–tandem mass spectrometry

Hyo-Ji Kim, Kyung-Ah Seo, Hyun-Mi Kim et al. · Journal of Pharmaceutical and Biomedical Analysis · 2014 · 100 citations

Accurate Quantitative Analysis, Medicine, Bioanalysis +11